logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Bronchitis

    FiltersReset Filters
    27 results
    • azithromycin

      (AZITHROMYCIN MONOHYDRATE)
      Lannett Company, Inc.
      Usage: Azithromycin is a macrolide antibacterial indicated for mild to moderate infections in adults and pediatrics, including respiratory infections, skin infections, and certain sexually transmitted infections. It should only be used when infections are confirmed or strongly suspected to be due to susceptible bacteria to prevent resistance.
    • azithromycin

      (Azithromycin)
      Alembic Pharmaceuticals Limited
      Usage: Azithromycin is indicated for treating mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerbations of chronic bronchitis, sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, skin infections, urethritis, cervicitis, and genital ulcer disease in men. Pediatric uses include acute otitis media and pneumonia in older children.
    • azithromycin

      (Azithromycin)
      Alembic Pharmaceuticals Inc.
      Usage: Azithromycin tablets are indicated for treating mild to moderate infections in adults and pediatric patients, including respiratory infections, skin infections, pharyngitis, and certain sexually transmitted infections. It is crucial to use azithromycin for infections caused by susceptible strains to prevent drug resistance.
    • cefdinir

      (cefdinir)
      Ascend Laboratories, LLC
      Usage: Cefdinir is indicated for treating mild to moderate infections caused by susceptible bacteria. This includes community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections, in both adults and pediatric patients. It should only be used when bacterial susceptibility is confirmed or suspected.
    • cefdinir

      (Cefdinir)
      Lupin Pharmaceuticals Inc
      Usage: Cefdinir capsules are indicated for mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. The drug aims to prevent drug-resistant bacteria development and should be used based on culture and susceptibility data when available.
    • cefdinir

      (Cefdinir)
      Teva Pharmaceuticals USA, Inc.
      Usage: Cefdinir for oral suspension is indicated for treating mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections in both adults and pediatric patients.
    • cefdinir

      (Cefdinir)
      Lupin Pharmaceuticals Inc
      Usage: Cefdinir for oral suspension is indicated for treating mild to moderate infections caused by susceptible bacteria, including community-acquired pneumonia, acute bronchitis exacerbations, acute sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections. It should be used judiciously to prevent antibiotic resistance.
    • cefpodoxime proxetil

      (CEFPODOXIME PROXETIL)
      Cronus Pharma LLC
      Usage: Cefpodoxime proxetil is indicated for mild to moderate infections, including acute otitis media, pharyngitis, community-acquired pneumonia, bronchitis exacerbations, gonorrhea, skin infections, maxillary sinusitis, and uncomplicated urinary tract infections, caused by susceptible bacteria. Dosages and therapy durations vary by infection type.
    • cefprozil

      (Cefprozil)
      Ascend Laboratories, LLC
      Usage: Cefprozil is indicated for mild to moderate infections caused by specific bacteria, including pharyngitis/tonsillitis, otitis media, acute sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated skin infections. It should be used selectively to prevent drug-resistant bacteria development.
    • cefprozil

      (Cefprozil)
      Aurobindo Pharma Limited
      Usage: Cefprozil is indicated for treating mild to moderate infections caused by susceptible bacteria, including pharyngitis, otitis media, acute sinusitis, acute bacterial exacerbation of chronic bronchitis, and uncomplicated skin infections. It should be used judiciously to prevent drug-resistant bacteria development.